RedHill Biopharma, a specialty biopharmaceutical company with a focus on developing treatments for the bacterial infection H. pylori, has renewed its contract with Medi-Cal, California's Medicaid healthcare program.
GI & Endoscopy
A multicenter prospective cohort study of patients with Crohn's disease found that patients who received high concentrations of anti-tumor necrosis factor therapy were linked to a greater probability of sustained remission, Medscape Medical News reported Oct. 1.
A physician who formerly worked at Steward Easton (Pa.) Hospital has agreed to pay $45,000 plus interest to resolve allegations that he submitted false claims to Medicaid and Medicare by improperly billing esophagogastroduodenoscopies.
Evidence is mounting that the gut microbiome influences many major human diseases, according to a Sept. 23 Medscape Medical News article.
Colorectal cancer is the second-leading cause of cancer death in the U.S., with more than 150,000 patients diagnosed and treated annually.
Advertisement
The GI space saw numerous developments and industry moves in September.
Patients taking GLP-1 receptor agonists have a lower risk of food retention when an esophagogastroduodenoscopy is combined with a colonoscopy, according to an Oct. 1 MedPage Today report.
Blue Cross Blue Shield of Massachusetts is encouraging its members to review options for colorectal cancer screenings amid a rise in cases, according to an Oct. 1 news release from the insurer.
GI Alliance — the largest GI practice network in the country — will introduce Medtronic's GI Genius to its over 400 locations nationwide.
Over the last 20 years, incidences of upper gastrointestinal cancer have increased faster in young women than young men, according to a Sept. 30 report from Endocrinology Advisor.